Influence of age on the pharmacokinetics, pharmacodynamics, efficacy, and safety of rivaroxaban.
Kenneth Todd MoorePeggy WongLiping ZhangGuohua PanJoAnne FoodyPublished in: Current medical research and opinion (2018)
A favorable clinical profile with rivaroxaban was observed across age sub-groups, supporting the premise that dosing in older adults does not necessitate adjustment. However, it is prudent that a cautious and individualized approach is taken for treatment with any anticoagulant in older adults.